Hepatic encephalopathy-Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998
Tóm tắt
Từ khóa
Tài liệu tham khảo
Cordoba, 1996, Brain edema and hepatic encephalopathy, Semin Liver Dis, 16, 271, 10.1055/s-2007-1007240
Bustamante, 1999, Prognostic significance of hepatic encephalopathy in patients with cirrhosis, J Hepatol, 30, 890, 10.1016/S0168-8278(99)80144-5
Gitlin, 1986, The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis, J Hepatol, 3, 75, 10.1016/S0168-8278(86)80149-0
Ferenci, 1999, Evidence Based Gastroenterology and Hepatology, 443
Atterbury, 1978, Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial, Am J Dig Dis, 23, 398, 10.1007/BF01072921
Teasdale, 1978, Observer variability in assessing impaired consciousness and coma, J Neurol Neurosurg Psychiatry, 41, 603, 10.1136/jnnp.41.7.603
Conn, 1977, Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial, Gastroenterology, 72, 573, 10.1016/S0016-5085(77)80135-2
Reitan, 1955, The relation of the trail making test to organic brain damage, J Consult Psychol, 19, 393, 10.1037/h0044509
Conn, 1977, Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy, Am J Dig Dis, 22, 541, 10.1007/BF01072510
Weissenborn, 1998, The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy, J Hepatol, 28, 646, 10.1016/S0168-8278(98)80289-4
Amodio, 1996, Diagnostic tools for the detection of subclinical hepatic encephalopathy: comparison of standard and computerized psychometric tests, Metab Brain Dis, 11, 315, 10.1007/BF02029493
Kramer, 2000, Comparison of ammonia partial pressure and total ammonia in hepatic encephalopathy, Hepatology, 31, 30, 10.1002/hep.510310107
Tarter, 1984, Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy, Gastroenterology, 86, 1421, 10.1016/S0016-5085(84)80154-7
McCrea, 1996, Neuropsychological characterization and detection of subclinical hepatic encephalopathy, Arch Neurol, 53, 758, 10.1001/archneur.1996.00550080076015
Wechsler, 1981, Wechsler adult intelligence scale-revised
Schomerus, 1999, Der PSE-Syndrom-Test
Weissenborn, 2001, Neuropsychological characterization of hepatic encephalopathy, J Hepatol, 34, 768, 10.1016/S0168-8278(01)00026-5
Amodio, 1998, Visual attention in cirrhotic patients: a study on covert visual attention orienting, Hepatology, 27, 1517, 10.1002/hep.510270608
Amodio, 1998, Study on the Sternberg paradigm in cirrhotic patients without overt hepatic encephalopathy, Metab Brain Dis, 13, 159, 10.1023/A:1020665431411
Amodio, 1999, Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests, Hepatology, 29, 1662, 10.1002/hep.510290619
van der Rijt, 1992, Quantitative EEG analysis and evoked potentials to measure (latent) hepatic encephalopathy, J Hepatol, 14, 141, 10.1016/0168-8278(92)90148-I
Weissenborn, 1990, Neurophysiological assessment of early hepatic encephalopathy, Electroencephalogr Clin Neurophysiol, 75, 289, 10.1016/0013-4694(90)90107-U
Amodio, 1999, Spectral versus visual EEG analysis in mild hepatic encephalopathy, Clin Neurophysiol, 110, 1334, 10.1016/S1388-2457(99)00076-0
Epstein, 1992, EEG in liver transplantation: visual and computerized analysis, Electroencephalogr Clin Neurophysiol, 103, 302
Kullmann, 1995, Subclinical hepatic encephalopathy: the diagnostic value of evoked potentials, J Hepatol, 22, 101, 10.1016/0168-8278(95)80267-3
Groeneweg, 1998, Subclinical hepatic encephalopathy impairs daily functioning, Hepatology, 28, 45, 10.1002/hep.510280108
Marchesini, 2001, Factors associated with poor health-related quality of life of patients with cirrhosis, Gastroenterology, 120, 170, 10.1053/gast.2001.21193
Bernthal, 1987, Cerebral CT scan abnormalities in cholestatic and hepatocellular disease and their relationship to neuropsychologic test performance, Hepatology, 7, 107, 10.1002/hep.1840070122
Zeneroli, 1987, Prevalence of brain atrophy in liver cirrhosis patients with chronic persistent encephalopathy. Evaluation by computed tomography, J Hepatol, 4, 283, 10.1016/S0168-8278(87)80536-6
Inoue, 1991, Portalsystemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MRI images, Radiology, 179, 551, 10.1148/radiology.179.2.2014310
Zeneroli, 1991, Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy, Magnet Res Imaging, 9, 295, 10.1016/0730-725X(91)90414-H
Weissenborn, 1995, Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation, Metabol Brain Dis, 10, 219, 10.1007/BF02081027
Pujol, 1993, Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure, Neurology, 43, 65, 10.1212/WNL.43.1_Part_1.65
Pomier-Layrargues, 1995, Increased manganese concentrations in pallidum of cirrhotic patients [Letter], Lancet, 345, 735, 10.1016/S0140-6736(95)90909-5
Krieger, 1995, Manganese and chronic hepatic encephalopathy, Lancet, 346, 2707, 10.1016/S0140-6736(95)92164-8
Ross, 1994, Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities, Radiology, 193, 457, 10.1148/radiology.193.2.7972763
Laubenberger, 1997, Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis, Gastroenterology, 112, 1610, 10.1016/S0016-5085(97)70043-X
Taylor-Robinson, 1994, Cerebral phosphorus31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy, Hepatology, 20, 1173, 10.1002/hep.1840200511
Lockwood, 1191, Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy, J Cerebr Blood Flow Metab, 11, 337, 10.1038/jcbfm.1991.67